Sign In
Samples
/
Kisqali
Oncology
Kisqali
ribociclib
Manufacturer
Novartis
Indication
CDK4/6 inhibitor for HR+/HER2- breast cancer
Restrictions:
Oncology specialty required
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with Novartis
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from Novartis
View all
Entresto
sacubitril/valsartan
Cardiovascular
Cosentyx
secukinumab
Immunology
Aimovig
erenumab-aooe
Neurology
Kesimpta
ofatumumab
Neurology
Leqvio
inclisiran
Cardiovascular
More Oncology Samples
View all
Keytruda
pembrolizumab
Merck
Tecentriq
atezolizumab
Genentech (Roche)
Darzalex
daratumumab
Janssen (J&J)
Tagrisso
osimertinib
AstraZeneca
Herceptin
trastuzumab
Genentech (Roche)
Ibrance
palbociclib
Pfizer
Popular Samples
Browse all
Mounjaro
tirzepatide
Eli Lilly
Diabetes
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Zepbound
tirzepatide
Eli Lilly
Obesity
Eliquis
apixaban
Pfizer
Cardiovascular
Dupixent
dupilumab
Sanofi
Immunology
Jardiance
empagliflozin
Eli Lilly
Diabetes
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas
Kisqali (ribociclib) Drug Samples | PrescriberPoint | PrescriberPoint